Numis at a glance

Latest Transactions
Micro Focus
£5.1bn
Acted as financial adviser, joint Rule 3 adviser and corporate broker
August 2022
Frasers
c.£13.6m
Acted as sole financial adviser
August 2022

Oxford Nanopore Technologies IPO

Numis acts as Joint Bookrunner to Oxford Nanopore Technologies in relation to its IPO.

Internal banner
Numis is proud to have supported Oxford Nanopore on a major milestone - its IPO on the main market of the London Stock Exchange.

Founded in 2005, Oxford Nanopore is a UK-based spin-out from the University of Oxford, with a simple, bold mission: to enable the analysis of anything, by anyone, anywhere.

The £602.8m fundraise had strong support from global investors, including a £150m cornerstone commitment from Oracle Corporation, which comes in parallel with a research collaboration between the two organisations.

Oxford Nanopore

“We have a longstanding relationship with the team at Oxford Nanopore and it’s a privilege to work with this dynamic growth company, which is a pioneer in the field of nanopore sensing. The IPO now positions the company for the next stage of its development, as the management team continues to pursue its ambitious growth plans.”

James Taylor Head of Investment Banking
This comes on the back of other recent high-profile IPOs for which Numis has advised, including Auction Technology Group and Victorian Plumbing.

The deal team at Numis was led by James Taylor and Freddie Barnfield, Co-Head of Healthcare Investment Banking.

Our services

Numis is an ambitious, dynamic and innovative investment bank, driven to excel across all aspects of its delivery.
Corporate broking

The largest corporate broker in the UK by number of listed clients

Equity capital markets

Capital raising specialists in services including IPOs, equity issuance and block trades

M&A

Providing M&A expertise through a full suite of bespoke advice and solutions

Debt advisory

Expert debt advice focused on robust and efficient corporate solutions

IPOs

Drawing from our experience to deliver strong outcomes at IPO

Growth capital solutions

Enabling the world’s most ambitious private companies to achieve their ambitions

Sales & Research

We are the leading provider of in-depth, high quality research on UK listed companies

Trading and sales trading (high-touch and low-touch execution)

The largest, most experienced Sales Trading and Trading teams covering UK equities

Investment companies

Proactive advice combining in-depth research, distribution and execution

Equities

Sales & Research

We are the leading provider of in-depth, high quality research on UK listed companies

Trading and sales trading (high-touch and low-touch execution)

The largest, most experienced Sales Trading and Trading teams covering UK equities

Investment companies

Proactive advice combining in-depth research, distribution and execution